Nanobiotix (NBTX) Projected to Post Earnings on Tuesday

Nanobiotix (NASDAQ:NBTX - Get Free Report) is expected to post its Q1 2025 quarterly earnings results before the market opens on Tuesday, May 20th. Analysts expect Nanobiotix to post earnings of ($0.58) per share and revenue of $3.55 million for the quarter.

Nanobiotix Price Performance

NASDAQ:NBTX traded up $0.22 on Friday, hitting $3.89. The company had a trading volume of 7,809 shares, compared to its average volume of 15,394. The firm has a 50 day moving average of $3.40 and a two-hundred day moving average of $3.45. Nanobiotix has a 52 week low of $2.76 and a 52 week high of $7.41.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. Guggenheim dropped their price target on shares of Nanobiotix from $12.00 to $8.00 and set a "buy" rating for the company in a research note on Friday, April 4th. UBS Group raised shares of Nanobiotix to a "hold" rating in a research note on Monday, February 17th.

Nanobiotix Company Profile

Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.